Can I take ashwagandha with fatty liver disease? This question is increasingly common as herbal supplements gain popularity in the UK. Ashwagandha (Withania somnifera) is a traditional Ayurvedic herb marketed for stress relief and wellbeing, whilst non-alcoholic fatty liver disease (NAFLD) affects a significant proportion of UK adults. However, emerging case reports of liver injury linked to ashwagandha raise important safety concerns. With no licensed pharmacological treatment for NAFLD and limited evidence on herbal supplements in this population, understanding the risks and alternatives is essential. This article examines the current evidence, potential hepatotoxicity risks, and evidence-based approaches to managing fatty liver disease safely.
Summary: There is currently no definitive evidence that ashwagandha is safe for individuals with fatty liver disease, and emerging case reports document liver injury associated with its use.
- Ashwagandha is a herbal supplement not licensed as a medicine in the UK and lacks rigorous safety testing in people with liver disease.
- Case reports have documented drug-induced liver injury ranging from mild enzyme elevations to acute liver failure requiring transplantation.
- Individuals with pre-existing liver disease may have reduced capacity to safely metabolise herbal compounds.
- NICE guidance recommends lifestyle modification—not herbal supplements—as the evidence-based treatment for NAFLD.
- Always consult your GP or hepatologist before taking ashwagandha if you have fatty liver disease, and report any suspected adverse reactions via the MHRA Yellow Card Scheme.
Table of Contents
Am I eligible for weight loss injections?
Find out whether you might be eligible!
Answer a few quick questions to see whether you may be suitable for prescription weight loss injections (like Wegovy® or Mounjaro®).
- No commitment — just a quick suitability check
- Takes about 1 minute to complete
Understanding Ashwagandha and Fatty Liver Disease
Ashwagandha (Withania somnifera) is a traditional herbal remedy widely used in Ayurvedic medicine, increasingly popular in the UK as a dietary supplement for stress reduction, sleep support, and general wellbeing. The root extract contains bioactive compounds called withanolides. Ashwagandha is traditionally described as an 'adaptogen'—a term used in herbal medicine to describe substances thought to help the body manage stress—though this concept is not a recognised pharmacological classification.
Non-alcoholic fatty liver disease (NAFLD) is a common condition characterised by excessive fat accumulation in liver cells (hepatic steatosis) in individuals who consume little or no alcohol. It affects a significant proportion of UK adults and is strongly associated with obesity, type 2 diabetes, and metabolic syndrome. NAFLD exists on a spectrum: simple steatosis may progress to non-alcoholic steatohepatitis (NASH), which involves inflammation and liver cell damage, potentially leading to fibrosis, cirrhosis, or hepatocellular carcinoma.
Management of NAFLD, as outlined by NICE guidance (NG49), focuses primarily on lifestyle modification—weight loss, dietary changes, and increased physical activity—to reduce hepatic fat and improve metabolic health. In primary care, risk stratification uses the FIB-4 score to identify patients who may need specialist referral and further assessment with the Enhanced Liver Fibrosis (ELF) blood test. There is currently no licensed pharmacological treatment specifically for NAFLD in the UK, though research into various agents continues.
Given the liver's central role in metabolising herbal supplements, individuals with existing liver conditions must exercise particular caution when considering complementary therapies. The question of whether ashwagandha is safe for those with fatty liver disease requires careful consideration of emerging evidence, potential hepatotoxicity risks, and the lack of robust clinical data in this specific population.
Can I Take Ashwagandha with Fatty Liver Disease?
There is currently no definitive clinical evidence to confirm that ashwagandha is either safe or beneficial specifically for individuals with fatty liver disease. Whilst some preliminary animal studies have suggested potential hepatoprotective properties of ashwagandha extracts—possibly through antioxidant mechanisms—these findings have not been replicated in well-designed human trials involving patients with NAFLD.
In the UK, most ashwagandha products are sold as food supplements, regulated under food law by the Food Standards Agency (FSA), meaning they have not undergone the rigorous safety and efficacy testing required for licensed medicines. Some herbal products may hold a Traditional Herbal Registration (THR) from the Medicines and Healthcare products Regulatory Agency (MHRA), which indicates the product meets quality and safety standards for traditional use, though not proof of efficacy. This regulatory landscape means there is limited oversight regarding product quality, standardisation of active ingredients, or monitoring of adverse effects in vulnerable populations, including those with liver disease.
If you have been diagnosed with fatty liver disease, it is essential to consult your GP or hepatologist before starting ashwagandha or any herbal supplement. Your healthcare provider can assess your individual circumstances, including:
-
The severity of your liver condition (simple steatosis versus NASH)
-
Current liver function test results and fibrosis risk scores
-
Other medications you are taking that might interact
-
Your overall metabolic health and comorbidities
Ashwagandha is not recommended during pregnancy or breastfeeding and may affect thyroid function, so medical advice is particularly important if you have thyroid disease or are taking thyroid medication. Self-prescribing supplements without medical guidance may inadvertently worsen liver inflammation or mask important symptoms. Your doctor may recommend baseline and follow-up liver function tests if you do decide to use ashwagandha, allowing early detection of any hepatotoxic effects. Patient safety must always take precedence over unproven complementary therapies, particularly when liver health is already compromised.
When choosing herbal products, look for the THR logo where applicable, which indicates the product has been registered with the MHRA for traditional use. Always inform your GP or pharmacist about any supplements you are taking.
Potential Risks of Ashwagandha for Liver Health
Whilst ashwagandha has been used traditionally for centuries, emerging case reports have documented instances of drug-induced liver injury (DILI) associated with its use. The US National Institutes of Health LiverTox database and peer-reviewed case series have recorded cases of hepatotoxicity ranging from mild transaminase elevations to acute liver failure requiring transplantation, though such severe cases remain rare.
The mechanism of ashwagandha-related liver injury is not fully understood but may involve:
-
Idiosyncratic reactions: Unpredictable immune-mediated responses in susceptible individuals
-
Direct hepatotoxicity: Certain withanolides or other constituents may be toxic to hepatocytes at high doses
-
Contaminants or adulterants: Poor quality control in supplement manufacturing can result in heavy metal contamination or inclusion of undeclared ingredients
-
Herb-drug interactions: Ashwagandha may affect drug-metabolising enzymes in laboratory studies, though clinical significance in humans is not well established
Individuals with pre-existing liver disease, including fatty liver, may have reduced hepatic reserve and impaired detoxification capacity, potentially increasing vulnerability to supplement-related injury. The liver's compromised state means it may be less able to process and eliminate herbal compounds safely.
Warning signs of liver injury that warrant immediate medical attention include:
-
Jaundice (yellowing of skin or eyes)
-
Dark urine or pale stools
-
Persistent nausea, vomiting, or loss of appetite
-
Right upper abdominal pain
-
Unexplained fatigue or malaise
If you are taking ashwagandha and develop any of these symptoms, stop the supplement immediately and contact your GP urgently. If you experience severe jaundice accompanied by confusion, unusual bleeding or bruising, or rapidly worsening symptoms, seek emergency medical care, as these may indicate acute liver failure.
Early recognition and cessation of the causative agent is crucial in preventing progression to serious liver damage. If you suspect an adverse reaction to ashwagandha or any herbal product, you can report it via the MHRA Yellow Card Scheme online at yellowcard.mhra.gov.uk or through the Yellow Card app. This helps improve the safety monitoring of herbal supplements.
Evidence on Herbal Supplements and Liver Function
The relationship between herbal supplements and liver health is complex and increasingly recognised as a significant clinical concern. Herbal and dietary supplement-induced liver injury (HILI) now accounts for a notable proportion of all drug-induced liver injury cases in Western countries, according to data from liver injury registries and the European Association for the Study of the Liver (EASL) Clinical Practice Guidelines on drug-induced liver injury.
Systematic reviews have highlighted that many herbal products lack adequate safety data, particularly in populations with existing liver disease. The variability in supplement composition—due to differences in plant species, growing conditions, extraction methods, and manufacturing processes—makes it difficult to predict safety profiles or standardise dosing recommendations.
Green tea extracts, kava, and certain traditional Chinese medicine preparations have well-documented hepatotoxic potential. Whilst ashwagandha has a shorter history of reported liver injury in Western medical literature, the increasing popularity and consumption of this supplement means more cases may emerge over time.
The challenge for clinicians and patients lies in the lack of pre-market safety testing for food supplements. Unlike licensed medicines, herbal products sold as food supplements do not require proof of safety or efficacy before reaching consumers. Post-market surveillance relies heavily on voluntary reporting systems such as the MHRA Yellow Card Scheme, which likely underestimate the true incidence of adverse effects.
NICE guidance on NAFLD (NG49) does not recommend any herbal supplements as part of standard management. The evidence base for lifestyle interventions—particularly weight loss of 7–10% of body weight—is far more robust than for any complementary therapy. Patients should be counselled that unproven supplements may divert attention and resources from evidence-based treatments that genuinely improve liver outcomes, such as dietary modification, exercise, and management of metabolic risk factors like diabetes and dyslipidaemia.
Safe Alternatives and Lifestyle Approaches for Fatty Liver
Rather than relying on unproven supplements, evidence-based lifestyle modifications remain the cornerstone of NAFLD management and have been shown to reduce hepatic steatosis, improve liver enzymes, and potentially reverse early-stage disease.
Dietary approaches recommended by NICE and supported by robust evidence include:
-
Mediterranean-style diet: Rich in vegetables, fruits, whole grains, legumes, nuts, and olive oil, with moderate fish consumption and limited red meat
-
Caloric restriction: Achieving an energy deficit of around 600 kcal per day to promote gradual weight loss
-
Reducing refined carbohydrates and added sugars: Particularly fructose-containing beverages, which are strongly linked to hepatic fat accumulation
-
Limiting saturated fats: Whilst increasing intake of omega-3 fatty acids from oily fish
Physical activity is equally important. The UK Chief Medical Officers' Physical Activity Guidelines recommend at least 150 minutes of moderate-intensity aerobic exercise weekly, combined with resistance training. Exercise improves insulin sensitivity and reduces liver fat even without significant weight loss.
Weight management is perhaps the most powerful intervention: studies demonstrate that losing 7–10% of body weight can resolve NASH and reduce fibrosis in many patients. This should be achieved gradually through sustainable lifestyle changes rather than crash dieting. Your GP can refer you to NHS weight management services or a dietitian for structured support.
Medical management of associated conditions is also crucial:
-
Optimising control of type 2 diabetes with metformin or other appropriate agents
-
Managing dyslipidaemia with statins (which are safe in NAFLD)
-
Treating hypertension to reduce cardiovascular risk
Alcohol intake should be kept within UK low-risk drinking guidelines (no more than 14 units per week, spread over 3 or more days, with several alcohol-free days).
If you are considering supplements for general health, discuss safer, evidence-based options with your GP. Vitamin D supplementation may be appropriate if you are deficient, and omega-3 fatty acids may be considered for hypertriglyceridaemia, but neither is a treatment for NAFLD itself. Always inform your healthcare team about any supplements you are taking, as this information is vital for monitoring your liver health and avoiding potential interactions. Regular follow-up with liver function tests and risk stratification (using FIB-4 and, where indicated, the ELF test) allows early detection of disease progression and ensures your management plan remains appropriate for your individual circumstances.
Frequently Asked Questions
Is ashwagandha safe if I have fatty liver disease?
There is no definitive evidence confirming ashwagandha is safe for people with fatty liver disease, and emerging case reports document liver injury associated with its use. Always consult your GP or hepatologist before taking ashwagandha if you have any form of liver disease, as your compromised liver may be less able to safely process herbal compounds.
Can ashwagandha help improve my fatty liver?
There is no robust clinical evidence that ashwagandha improves fatty liver disease in humans, despite some preliminary animal studies suggesting potential benefits. NICE guidance recommends lifestyle modification—particularly weight loss, dietary changes, and exercise—as the evidence-based approach to managing NAFLD, not herbal supplements.
What are the warning signs of liver damage from ashwagandha?
Warning signs include jaundice (yellowing of skin or eyes), dark urine, pale stools, persistent nausea or vomiting, right upper abdominal pain, and unexplained fatigue. If you develop any of these symptoms whilst taking ashwagandha, stop the supplement immediately and contact your GP urgently, as early recognition and cessation is crucial to prevent serious liver damage.
Should I tell my doctor I'm taking herbal supplements for my liver?
Yes, always inform your GP or hepatologist about any herbal supplements you are taking, as this information is vital for monitoring your liver health and avoiding potential interactions with prescribed medications. Your doctor may recommend baseline and follow-up liver function tests if you use supplements, allowing early detection of any hepatotoxic effects.
What's the difference between ashwagandha and prescribed medicines for fatty liver?
Ashwagandha is sold as a food supplement in the UK and has not undergone the rigorous safety and efficacy testing required for licensed medicines. There is currently no licensed pharmacological treatment specifically for NAFLD in the UK, and management focuses on evidence-based lifestyle interventions such as weight loss, dietary modification, and increased physical activity.
How do I report a suspected reaction to ashwagandha?
You can report suspected adverse reactions to ashwagandha or any herbal product via the MHRA Yellow Card Scheme online at yellowcard.mhra.gov.uk or through the Yellow Card app. This voluntary reporting helps improve safety monitoring of herbal supplements and protects other patients from potential harm.
The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.
The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Heading 6
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Block quote
Ordered list
- Item 1
- Item 2
- Item 3
Unordered list
- Item A
- Item B
- Item C
Bold text
Emphasis
Superscript
Subscript
